Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RGNX will decline by -9.20% over the next 2 Weeks and hit $8.24 by Monday, July 6, 2026. In that time frame, RGNX's share price is expected to range between $6.59 and $9.90.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 6, 2026 | 6.59 | 8.24 | 9.90 |
| Jul 3, 2026 | 6.30 | 7.93 | 9.44 |
| Jul 2, 2026 | 6.79 | 8.40 | 9.98 |
| Jul 1, 2026 | 6.95 | 8.62 | 10.25 |
| Jun 30, 2026 | 6.88 | 8.46 | 10.12 |
| Jun 29, 2026 | 7.03 | 8.65 | 10.29 |
| Jun 26, 2026 | 6.77 | 8.34 | 9.99 |
| Jun 25, 2026 | 7.14 | 8.81 | 10.51 |
| Jun 24, 2026 | 7.42 | 9.04 | 10.62 |
| Jun 23, 2026 | 7.22 | 8.87 | 10.62 |
RGNX shares rose +9.70% in Tuesday, June 23, 2026's trading session, rising from a previous close of $9.07 to move at $9.95. The stock demonstrated notable intraday movement (see RGNX's key stats for a full breakdown), fluctuating between $9.06 and $10.34, a +14.13% trading range. While recent weeks have seen some volatility, RGNX has managed to secure a +56.94% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 2.96M shares changing hands, 6.04M fewer than the previous session. This amounted to $29.47M in total market activity.
Will RGNX Continue Its Downward Trend?
According to analyst ratings and projections for RGNX, REGENXBIO Inc. shares are anticipated to decrease by -0.49%, potentially reaching $9.90 per share by July 6, 2026. Short-term technical indicators currently suggest a neutral sentiment for RGNX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the RGNX stock forecast, now is not the best time to buy RGNX stock because its current trading price is +20.81% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on RGNX covering social and institutional perspectives.
RGNX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RGNX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 64.20% to 80.37%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 53.40%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.74%, maintains a neutral outlook for the long term. Insights into RGNX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
REGENXBIO Short-Term Forecasts
RGNX Forecast For Next 5 Days
Our algorithm anticipates REGENXBIO (RGNX) stock could hit $9.04 by Jun 30, 2026. This represents a -9.14% fall from today's price, following a -6.50% change over the past five days.
RGNX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for REGENXBIO Inc. (RGNX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $8.28, which would mean a -16.78% decrease from the current price of $9.95. Projections for this period range from a high of $10.72 to a low of $5.78.
RGNX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for REGENXBIO's price over the next three months point to a rise. RGNX stock is expected to peak at $16.43 on Jun 23, 2026 before potentially dipping to $11.18 on Sep 23, 2026. On average, RGNX is likely to trade around $14.05 in the coming 90 days.
REGENXBIO Stock Forecast 2025
Based on our predictive models, REGENXBIO (RGNX) is expected to trade between $4.02 and $16.43 throughout 2026. This would result in an average price of $12.72, potentially offering investors a +27.84% return from current levels.
REGENXBIO Inc. Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, REGENXBIO Inc. (RGNX) is positioned to show a strong performance in June 2026. The price is predicted to move between $14.71 and $16.43, settling at an average of $15.56. This could translate to a +56.38% gain.
July 2026
Based on current market signals, REGENXBIO Inc. is projected to trend july 2026. We forecast a trading range from $12.91 to $15.22, with a likely average price of $13.86. Investors could expect a potential return of +39.30%.
August 2026
Our predictive algorithms indicate REGENXBIO Inc. stock may see a shift in August 2026. The expected range spans $13.25–$15.12, with an average target of $14.27. This represents a positive outlook and a possible gain of +43.42%.
September 2026
Analyzing established trends, REGENXBIO Inc. looks set to move in September 2026. Projections place the stock between $10.73 and $14.97, averaging around $13.28. This suggests a +33.47% gain from current levels.
October 2026
Market indicators suggest REGENXBIO Inc. could experience notable changes during October 2026. Prices could fluctuate within $8.44 to $12.66, with a midpoint forecast of $11.72. The stock might deliver a +17.79% gain.
November 2026
Forecasting for November 2026, models estimate that REGENXBIO Inc. may undergo key fluctuations. If trends hold, the stock might trade between $6.50 and $12.36, averaging $11.57. This signals a positive trajectory with potential returns around +16.28%.
December 2026
According to our latest forecast models, REGENXBIO Inc. (RGNX) is positioned to show a strong performance in December 2026. The price is predicted to move between $4.02 and $11.46, settling at an average of $10.89. This could translate to a +9.45% gain.
January 2027
Based on current market signals, REGENXBIO Inc. is projected to trend january 2027. We forecast a trading range from $0.95 to $10.85, with a likely average price of $10.48. Investors could expect a potential return of +5.33%.
February 2027
Our predictive algorithms indicate REGENXBIO Inc. stock may see a shift in February 2027. The expected range spans $0.00–$8.77, with an average target of $8.90. This represents a cautious outlook and a possible loss of -10.55%.
March 2027
Analyzing established trends, REGENXBIO Inc. looks set to move in March 2027. Projections place the stock between $0.00 and $7.93, averaging around $8.68. This suggests a -12.76% loss from current levels.
April 2027
Market indicators suggest REGENXBIO Inc. could experience notable changes during April 2027. Prices could fluctuate within $0.00 to $6.42, with a midpoint forecast of $6.78. The stock might deliver a -31.86% loss.
May 2027
Forecasting for May 2027, models estimate that REGENXBIO Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $4.06, averaging $5.50. This signals a cautious trajectory with potential returns around -44.72%.
June 2027
According to our latest forecast models, REGENXBIO Inc. (RGNX) is positioned to show a strong performance in June 2027. The price is predicted to move between $0.00 and $3.56, settling at an average of $5.51. This could translate to a -44.62% loss.
RGNX's history of dividends and stock splits also plays a role in long-term investor confidence.